CS logo
small CS logo
Georgia Pollens Clinical Research Centers, Inc.

Albany, Georgia, United States
Medical clinic in Lee County, Georgia
105 Spanish Ct, Albany, GA 31707

About Georgia Pollens Clinical Research Centers, Inc.


"We are a multi-provider allergy and asthma practice dedicated to helping the people of South Georgia."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Georgia Pollens Clinical Research Centers, Inc.


During the past decade, Georgia Pollens Clinical Research Centers, Inc. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
1997-08-01
Completed
18
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
1997-09-01
2002-04-01
Completed
63
Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
2000-03-01
2012-07-01
Completed
44
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
1999-11-01
Completed
55
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
2000-12-01
Completed
160
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
2002-07-01
Completed
40
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
2002-07-01
Completed
40
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
2002-07-01
Completed
40

Rows per page:

1–100 of 427

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Georgia Pollens Clinical Research Centers, Inc." #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored, "LEO Pharma" with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Pollens Clinical Research Centers, Inc." #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Georgia Pollens Clinical Research Centers, Inc.


According to Clinical.Site data, the most researched conditions in "Georgia Pollens Clinical Research Centers, Inc." are "Asthma" (7 trials), "Atopic Dermatitis" (6 trials), "Primary Immunodeficiency Diseases (PID)" (2 trials), "Food Hypersensitivity" (1 trials) and "Perennial Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Georgia Pollens Clinical Research Centers, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Georgia Pollens Clinical Research Centers, Inc.


Most popular intervention types in "Georgia Pollens Clinical Research Centers, Inc." are "Drug" (12 trials), "Biological" (6 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Lebrikizumab" (5 trials), "Omalizumab" (3 trials), "HYQVIA" (2 trials) and "0.15% azelastine hydrochloride" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Georgia Pollens Clinical Research Centers, Inc.


The vast majority of trials in "Georgia Pollens Clinical Research Centers, Inc." are 19 trials for "All" genders.

Clinical Trials Status at Georgia Pollens Clinical Research Centers, Inc.


Currently, there are NaN active trials in "Georgia Pollens Clinical Research Centers, Inc.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Georgia Pollens Clinical Research Centers, Inc., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Georgia Pollens Clinical Research Centers, Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status